Letter: telaprevir triple therapy in chronic hepatitis C genotype 1 patients receiving haemodialysis

被引：16
|
作者：
Wiegand, J. [1 ]
Maasoumy, B. [2 ]
Buggisch, P. [3 ]
Buslau, A. [4 ]
Schiefke, I. [5 ]
Berg, T. [1 ]
Wedemeyer, H.
Sarrazin, C. [4 ]
Hinrichsen, H. [6 ]
机构：
[1] Univ Klinikum Leipzig, Klin Gastroenterol & Rheumatol, Leipzig, Germany
[2] Hannover Med Sch, Abt Gastroenterol Hepatol & Endokrinol, D-30623 Hannover, Germany
[3] Inst Interdisziplinare Med Hamburg, Hamburg, Germany
[4] Univ Frankfurt Klinikum, Med Klin 1, Frankfurt, Germany
[5] Krankenhaus St Georg Leipzig, Klin Gastroenterol & Hepatol, Leipzig, Germany
[6] Gastroenterol Hepatol Zentrum Kiel, Kiel, Germany
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 39卷 / 11期
关键词：
BUDD-CHIARI-SYNDROME; MANAGEMENT; TIPS;
D O I：
10.1111/apt.12748
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1342 / 1344
页数：3
相关论文
共 50 条
  • [21] Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
    Mauss, Stefan
    Eisenbach, Christoph
    Heyne, Renate
    Moog, Gero
    Lutz, Thomas
    Naumann, Uwe
    Geissler, Michael
    Pape, Stefan
    Mordeja, Matthias
    Herold, Christoph
    Simon, Karl-Georg
    Isernhagen, Konrad
    Alshuth, Ulrich
    Buggisch, Peter
    Hueppe, Dietrich
    HEPATOLOGY, 2013, 58 : 1112A - 1112A
  • [22] Efficacy and safety of telaprevir-based triple therapy for patients aged 66 years and older with genotype 1b chronic hepatitis C
    Yamagiwa, Satoshi
    Ishikawa, Toru
    Tsubata, Shunsuke
    Waguri, Nobuo
    Sugitani, Soichi
    Wakabayashi, Hiroto
    Takamura, Masaaki
    Igarashi, Masato
    Nomoto, Minoru
    HEPATOLOGY, 2014, 60 : 691A - 692A
  • [23] Viral Hepatitis ( plus Antiviral Therapy) Efficacy of telaprevir-based triple therapy for genotype 1 hepatitis patients in Japan
    Sasaki, Masato
    Yoshida, Kenichi
    Inamura, Kazuki
    Obata, Masahiro
    Yoshinari, Motonari
    Idegami, Junko
    Tanaka, Hideki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 423 - 423
  • [24] Evaluation of telaprevir-containing triple therapy in the treatment of chronic hepatitis C in hemodialysed patients
    Kaya, Safak
    Aksoz, Selcuk
    Baysal, Birol
    Ay, Nurettin
    Danis, Ramazan
    INFECTIOUS DISEASES, 2015, 47 (09) : 658 - 661
  • [25] The Effect of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients on Gastric Emptying
    Arai, Makoto
    Oyamada, Arata
    Maruoka, Daisuke
    Matsumura, Tomoaki
    Nakagawa, Tomoo
    Kanda, Tastuo
    Katsuno, Tatsuro
    Imazeki, Fumio
    Yokosuka, Osamu
    GASTROENTEROLOGY, 2014, 146 (05) : S615 - S616
  • [26] Effect of telaprevir-based triple therapy on the renal function of chronic hepatitis C patients
    Ozeki, Itaru
    Nakzima, Tomoaki
    Hige, Shuhei
    Karino, Yoshiyasu
    HEPATOLOGY, 2012, 56 : 1040A - 1040A
  • [27] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Loustaud-Ratti, Veronique
    Carrier, Paul
    Vong, Chanlina
    Essig, Marie
    HEPATOLOGY, 2014, 59 (06) : 2426 - 2426
  • [28] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Mauss, Stefan
    Hueppe, Dietrich
    Alshuth, Ulrich
    HEPATOLOGY, 2014, 59 (01) : 46 - 48
  • [29] Telaprevir for Chronic Hepatitis C with Genotype 1: A Meta-Analysis
    Dang, Shuang-Suo
    Wang, Wen-Jun
    Wang, Xiu-Fang
    Li, Ya-Ping
    Li, Mei
    Jia, Xiao-Li
    Wang, Yuan
    Liu, Enqi
    Zhao, Sihai
    HEPATO-GASTROENTEROLOGY, 2012, 59 (114) : 461 - 468
  • [30] Effectiveness of telaprevir/boceprevir-based triple therapy for chronic hepatitis c
    Garcia-Queiruga, Marta
    Purificacion, Cid
    Laura Maria, Martinez-Lopez
    Marta, Leston
    Luis, Margusino
    Isabel, Martin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 280 - 281
12345